{
    "id": 28578,
    "fullName": "EGFR S645C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR S645C lies within the extracellular domain of the Egfr protein (UniProt.org). S645C results in increased Egfr phosphorylation in culture, promotes tumor formation in animal models, and confers resistance to erlotinib in culture (PMID: 27478040).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 8124,
                    "pubMedId": 27478040,
                    "title": "High-throughput Phenotyping of Lung Cancer Somatic Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27478040"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "S645C",
    "createDate": "08/22/2018",
    "updateDate": "08/23/2018",
    "referenceTranscriptCoordinates": {
        "id": 176623,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55172997C>G",
        "cDna": "c.1934C>G",
        "protein": "p.S645C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14992,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of EGFR S645C in lung adenocarcinoma cells harboring EGFR exon 19 deletion mutations led to resistance to Tarceva (erlotinib) in culture (PMID: 27478040).",
            "molecularProfile": {
                "id": 30470,
                "profileName": "EGFR exon 19 del EGFR S645C"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8124,
                    "pubMedId": 27478040,
                    "title": "High-throughput Phenotyping of Lung Cancer Somatic Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27478040"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30458,
            "profileName": "EGFR S645C",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30470,
            "profileName": "EGFR exon 19 del EGFR S645C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 176623,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55172997C>G",
            "cDna": "c.1934C>G",
            "protein": "p.S645C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 176624,
            "transcript": "NM_201284",
            "gDna": "chr7:g.55170360C>G",
            "cDna": "c.1934C>G",
            "protein": "p.S645C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}